Recombinant Human Kir2.1 protein (ab114391)


  • Product nameRecombinant Human Kir2.1 protein
  • Protein lengthProtein fragment


  • NatureRecombinant
  • SourceWheat germ
  • Amino Acid Sequence
    • AccessionP63252
    • SpeciesHuman
    • Molecular weight37 kDa including tags
    • Amino acids328 to 427


Our Abpromise guarantee covers the use of ab114391 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications


    Western blot


  • FormLiquid
  • Additional notesProtein concentration is above or equal to 0.05 mg/ml.
    ab114391 is best used within three months from the date of receipt.
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 8.00
    Constituents: 0.79% Tris HCl, 0.3% Glutathione

General Info

  • Alternative names
    • Cardiac inward rectifier potassium channel
    • HHBIRK 1
    • HHBIRK1
    • HHIRK 1
    • HHIRK1
    • HIRK 1
    • hIRK1
    • Inward rectifier K
    • Inward rectifier K(+) channel Kir2.1
    • Inward rectifier potassium channel 2
    • inwardly rectifying subfamily J member 2
    • IRK 1
    • IRK-1
    • IRK1
    • IRK2_HUMAN
    • KCNJ2
    • KIR2.1
    • LQT 7
    • LQT7
    • Potassium channel
    • Potassium channel inwardly rectifying subfamily J member 2
    • Potassium inwardly rectifying channel J2
    • Potassium inwardly rectifying channel subfamily J member 2
    • SQT 3
    • SQT3
    see all
  • FunctionProbably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium or cesium.
  • Tissue specificityHeart, brain, placenta, lung, skeletal muscle, and kidney. Diffusely distributed throughout the brain.
  • Involvement in diseaseDefects in KCNJ2 are the cause of long QT syndrome type 7 (LQT7) [MIM:170390]; also called Andersen syndrome or Andersen cardiodysrhythmic periodic paralysis. Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to excercise or emotional stress. LQT7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features.
    Defects in KCNJ2 are the cause of short QT syndrome type 3 (SQT3) [MIM:609622]. Short QT syndromes are heart disorders characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. They cause syncope and sudden death. SQT3 has a unique ECG phenotype characterized by asymmetrical T waves.
  • Sequence similaritiesBelongs to the inward rectifier-type potassium channel (TC 1.A.2.1) family. KCNJ2 subfamily.
  • Cellular localizationMembrane.
  • Information by UniProt

Recombinant Human Kir2.1 protein images

  • ab114391 analysed on a 12.5% SDS-PAGE Stained with Coomassie Blue.

References for Recombinant Human Kir2.1 protein (ab114391)

ab114391 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab114391.
Please use the links above to contact us or submit feedback about this product.